Gadea Grupo Farmacéutico (Gadea Pharmaceutical Group) R&D team specializes in the development of new processes, which can be designed to ensure the non-infringement of patents through the application of alternative synthesis procedures.
The correct management of R&D increases the competitiveness of the company, assures its continued successes and improves its position in the future market.
We search for the optimization of the R&D process and the continuous improvement to achieve the best results. Within 2009 Gadea Grupo Farmacéutico (Gadea Pharmaceutical Group) has reinvested 7% of it's revenues in R&D. 16% of our staff are exclusively involved in R&D. Gadea maintains a close cooperation with various prestigious international and domestic universities.